Pier Capital LLC Increases Stake in Quanterix Co. (NASDAQ:QTRX)

Pier Capital LLC boosted its holdings in Quanterix Co. (NASDAQ:QTRX - Free Report) by 32.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 679,680 shares of the company's stock after purchasing an additional 167,882 shares during the quarter. Pier Capital LLC owned about 1.76% of Quanterix worth $7,225,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. EntryPoint Capital LLC grew its holdings in shares of Quanterix by 117.8% during the fourth quarter. EntryPoint Capital LLC now owns 35,504 shares of the company's stock valued at $377,000 after buying an additional 19,203 shares during the last quarter. Vanguard Group Inc. boosted its stake in Quanterix by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 2,217,225 shares of the company's stock valued at $23,569,000 after purchasing an additional 19,386 shares during the last quarter. Fox Run Management L.L.C. increased its holdings in Quanterix by 258.7% during the 4th quarter. Fox Run Management L.L.C. now owns 43,784 shares of the company's stock worth $465,000 after purchasing an additional 31,577 shares in the last quarter. KLP Kapitalforvaltning AS bought a new position in shares of Quanterix in the fourth quarter valued at approximately $66,000. Finally, American Century Companies Inc. boosted its position in shares of Quanterix by 9.1% during the fourth quarter. American Century Companies Inc. now owns 71,992 shares of the company's stock valued at $765,000 after buying an additional 6,023 shares during the last quarter. Institutional investors own 86.48% of the company's stock.

Remove Ads

Quanterix Stock Down 3.1 %

QTRX stock traded down $0.21 during midday trading on Friday, hitting $6.56. The company's stock had a trading volume of 515,291 shares, compared to its average volume of 514,785. Quanterix Co. has a 1 year low of $6.30 and a 1 year high of $23.86. The stock has a market cap of $254.37 million, a price-to-earnings ratio of -6.19 and a beta of 1.33. The stock's 50-day moving average price is $7.99 and its 200 day moving average price is $10.64.

Quanterix (NASDAQ:QTRX - Get Free Report) last issued its quarterly earnings results on Monday, March 17th. The company reported ($0.30) earnings per share for the quarter, missing analysts' consensus estimates of ($0.27) by ($0.03). Quanterix had a negative return on equity of 11.74% and a negative net margin of 30.12%. The company had revenue of $35.16 million during the quarter, compared to analysts' expectations of $34.93 million. As a group, equities analysts forecast that Quanterix Co. will post -0.98 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

QTRX has been the topic of several recent analyst reports. Canaccord Genuity Group dropped their price objective on Quanterix from $20.00 to $15.00 and set a "buy" rating on the stock in a research note on Tuesday, March 18th. Scotiabank reissued an "outperform" rating on shares of Quanterix in a research report on Tuesday.

Quanterix Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.